Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up

Summary

HIV-infection is associated not only with a reduced function of the immune system, but also linked with diseases of other organ systems, in particular with the heart.

Heart conditions that have been described with HIV include

* Pericarditis,
* Pleural effusion
* Pulmonary hypertension (Venedic classification typ II)
* Dilated cardiomyopathy
* Heart failure
* Myocarditis
* Bacterial endocarditis
* Heart valve disorders In addition to previously stated disorders of the heart, the premature atherosclerosis of coronary arteries, a further even more important disease of the heart in this patient population, went into the focus of most HIV-researchers and physicians.

Premature atherosclerosis of coronary arteries results in coronary calcification, angina pectoris, myocardial infarction and sudden death. HIV-positive patients are at greater risk for a variety of heart-related conditions, including coronary artery disease. It is assumed, that HIV infection doubles the risk of a heart attack, according to recent research.

The reason for this link between HIV and heart-related conditions is unknown, but secondary infections that affect the heart muscle and coronary arteries have a greater chance of occurring in people with compromised immune systems. In addition, the HI-virus itself had been detected in the myocardium and might have an impact on the premature of cardiovascular diseases.

Furthermore, some of the medications used to treat HIV patients (antiretroviral therapy, ART) are assumed to have heart-related side effects.

Therefore, current treatment regimens for HIV infection have to be balanced against the marked benefits of antiretroviral treatment. Nevertheless, prevention of coronary heart disease should be integrated into current treatment procedures of HIV-infected patients.

The link between the heart and HIV is well established but not well understood. Therefore, further results are needed for efficient guidelines for the prevention, diagnostic and therapy of HIV-associated cardiovascular diseases.

Conditions

• Coronary Heart Disease
• Heart Failure
• HIV
• AIDS
• Metabolic Syndrome

Interventions

OTHER

Comprehensive non invasive cardiovascular examination

The examination includes: * Anamnesis incl. admission form * Physical examination * Documentation of the medical therapy (incl. HAART) * Electrocardiogram * Transthoracic echocardiography * Exercise electrocardiogram * 6 minute walk test * Blood collection * Questionnaire to quality of life and health economics

Sponsors & Collaborators

• HIV-HEART Study Investigative Group

  collaborator UNKNOWN

• German Heart Failure Network

  collaborator OTHER

• German Competence Network for HIV/AIDS

  collaborator OTHER

• German Federal Ministry of Education and Research

  collaborator OTHER_GOV

• Bristol-Myers Squibb

  collaborator INDUSTRY

• ViiV Healthcare

  collaborator INDUSTRY

• GlaxoSmithKline

  collaborator INDUSTRY

• Abbott

  collaborator INDUSTRY

• Boehringer Ingelheim

  collaborator INDUSTRY

• Merck Sharp & Dohme LLC

  collaborator INDUSTRY

• University Hospital, Essen

  lead OTHER

Principal Investigators

• Stefan Esser, MD · University Hospital, Essen

• Till Neumann, MD · University Hospital, Essen

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2009-12-31

Primary Completion

2011-12-31

Completion

2011-12-31

Countries

• Germany

Study Locations